Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
43.9 /100
Rank 74 out of 131 Industries -
Advance/Decline
15/9
-
No. of Companies24
-
Avg. Market Cap2,587
-
Price to Earning Ratio33.80
-
Price to Earning Growth Ratio0.20
-
Price to Book Ratio8.19
-
Return on Equity16.99
-
Return on Capital Employed-
-
Return on Assets14.98
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %88.99 %
-
Net Profit Growth Qtr YoY %56.25 %
-
Net Profit Growth Qtr QoQ %-48.41 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Usana Health Sciences Inc |
|
583.1
|
31.9
|
L
 1.7%
H
31.5
32.0
|
L
 -1.0%
H
31.4
32.3
|
L
 5.5%
H
28.5
32.3
|
L
 5.8%
H
28.5
38.3
|
L
 -21.5%
H
23.1
41.8
|
L
 -51.5%
H
23.1
69.6
|
L
 -59.4%
H
23.1
107.9
|
L
 -56.1%
H
23.1
138.0
|
Argen X SE - ADR |
|
43,586.6
|
712.2
|
L
 1.2%
H
702.4
716.6
|
L
 7.9%
H
674.5
716.6
|
L
 18.9%
H
596.0
716.6
|
L
 22.6%
H
510.1
716.6
|
L
 37.6%
H
510.1
716.6
|
L
 85.8%
H
327.7
716.6
|
L
 211.1%
H
212.7
716.6
|
L
H
17.3
716.6
|
Biondvax Pharmaceuticals L... |
|
-
|
1.5
|
L
 4.8%
H
1.5
1.6
|
L
 -4.4%
H
1.5
1.6
|
L
 -23.5%
H
1.4
2.0
|
L
 -43.1%
H
1.4
6.2
|
L
 -47.4%
H
1.4
6.2
|
L
 -86.5%
H
0.6
99
|
L
 -99.6%
H
0.6
499.0
|
L
 -95.8%
H
0.6
620
|
Cidara Therapeutics Inc |
|
1,658.2
|
65.4
|
L
 0.3%
H
63.8
65.7
|
L
 -1.5%
H
63.7
67.1
|
L
 5.6%
H
56.5
69.4
|
L
 197.0%
H
20.2
69.4
|
L
 404.9%
H
10.1
69.4
|
L
 -77.3%
H
10
840
|
L
 -95.1%
H
10
1408
|
L
 -98.9%
H
10
7228
|
Niagen Bioscience Inc. |
|
789.6
|
9.9
|
L
 0.8%
H
9.7
10.1
|
L
 -0.8%
H
9.6
10.3
|
L
 2.5%
H
8.8
11.3
|
L
 -8.5%
H
8.8
14.7
|
L
 194.6%
H
3.1
14.7
|
L
 582.8%
H
1.2
14.7
|
L
 95.3%
H
1.2
23.7
|
L
 172.0%
H
1.2
23.7
|
Cronos Group Inc |
|
995.6
|
2.6
|
L
H
2.5
2.7
|
L
H
2.5
2.7
|
L
 29.4%
H
1.9
2.8
|
L
 26.8%
H
1.8
2.8
|
L
 18.2%
H
1.6
2.8
|
L
 -17.7%
H
1.6
3.6
|
L
 -54.1%
H
1.6
15.8
|
L
H
0.2
25.1
|
Enveric Biosciences Inc |
|
3.7
|
1.1
|
L
 -10.3%
H
1.1
1.3
|
L
 -7.4%
H
1.1
1.5
|
L
 -8.1%
H
1.1
1.5
|
L
 -6.6%
H
1.1
1.5
|
L
 126%
H
0.3
4.8
|
L
 -80.8%
H
0.3
7.0
|
L
 -99.6%
H
0.3
752
|
L
 -100.0%
H
0.3
67500
|
Flora Growth Corp |
|
11.8
|
20.5
|
L
 -1.2%
H
20.5
22.1
|
L
 -3.6%
H
19.6
22.1
|
L
 -19.3%
H
15.2
25.4
|
L
 -23.5%
H
15.2
30.8
|
L
 -49.1%
H
15.2
82.3
|
L
 -96.9%
H
15.2
990.6
|
L
H
15.2
16731
|
L
H
15.2
16731
|
IM Cannabis Corp |
|
12.2
|
2.3
|
L
 -4.9%
H
2.3
2.6
|
L
 0.4%
H
2.2
2.6
|
L
 -13.1%
H
2.2
3.1
|
L
 -53.5%
H
2.2
7.1
|
L
 -7.2%
H
1.3
7.1
|
L
 -91.6%
H
0.4
29.8
|
L
 -99.2%
H
0.4
697.8
|
L
H
0.4
697.8
|
Lifevantage Corporation |
|
164.9
|
13.1
|
L
H
12.9
14.1
|
L
 0.2%
H
12.5
14.1
|
L
 1.5%
H
12.1
15
|
L
 3.5%
H
11.5
15
|
L
 68.6%
H
7.3
27.4
|
L
 247.5%
H
3.0
27.4
|
L
 -10.1%
H
3.0
27.4
|
L
 133.1%
H
2.9
27.4
|
Mannatech Inc |
|
18.2
|
9.6
|
L
 5.3%
H
9.2
9.6
|
L
 4.4%
H
8.7
9.6
|
L
 1.5%
H
7.6
10.9
|
L
 0.7%
H
7.5
11.4
|
L
 27.7%
H
7.1
16.5
|
L
 -61.7%
H
6.8
25.9
|
L
 -45.2%
H
6.8
49.1
|
L
 -45.4%
H
6.5
49.1
|
Natural Alternatives Inter... |
|
23.0
|
3.7
|
L
H
3.6
3.8
|
L
 -6.3%
H
3.6
4.0
|
L
 -1.8%
H
3.6
4.0
|
L
 11.0%
H
3.2
4.0
|
L
 -31.3%
H
2.6
6.9
|
L
 -67.8%
H
2.6
12.6
|
L
 -53.8%
H
2.6
19.9
|
L
 -35.5%
H
2.6
19.9
|
Nature`s Sunshine Products... |
|
297.2
|
16.9
|
L
 2%
H
16.5
16.9
|
L
 2.7%
H
16.1
17.0
|
L
 15.0%
H
13.9
17
|
L
 10.2%
H
13.3
17
|
L
 24.4%
H
11.0
18.1
|
L
 71.9%
H
7.9
21.7
|
L
 51.4%
H
7.9
21.7
|
L
 39.7%
H
5.5
21.7
|
Paranovus Entertainment Te... |
|
48.5
|
0.7
|
L
 4.4%
H
0.7
0.8
|
L
 2.9%
H
0.7
0.8
|
L
 -7.7%
H
0.7
1.0
|
L
 -24.2%
H
0.7
1.0
|
L
 -19.1%
H
0.3
1.5
|
L
 -83.6%
H
0.3
6.7
|
L
 -98.3%
H
0.3
51.6
|
L
H
0.3
122
|
PharmaCyte Biotech Inc |
|
6.5
|
0.9
|
L
 -2.1%
H
0.9
1.0
|
L
 -3.1%
H
0.9
1.0
|
L
 -7.8%
H
0.8
1.1
|
L
 -8.7%
H
0.8
1.2
|
L
 -40.1%
H
0.8
2.4
|
L
 -63.8%
H
0.8
3.2
|
L
 -95.1%
H
0.8
55.5
|
L
 -99.4%
H
0.8
253.4
|
ProPhase Labs Inc |
|
14.1
|
0.3
|
L
 -2.9%
H
0.3
0.4
|
L
 3.0%
H
0.3
0.4
|
L
 -2.9%
H
0.3
0.4
|
L
 -5.6%
H
0.3
0.5
|
L
 -85.8%
H
0.2
3
|
L
 -97.1%
H
0.2
12.9
|
L
 -87.6%
H
0.2
16.0
|
L
 -77.5%
H
0.2
16.0
|
Qualigen Therapeutics Inc |
|
3.0
|
1.8
|
L
 1.7%
H
1.7
1.9
|
L
 -3.8%
H
1.7
1.9
|
L
 -29.0%
H
1.6
2.6
|
L
 -52.9%
H
1.6
6.7
|
L
 -80.7%
H
0.1
10.5
|
L
 -99.1%
H
0.1
200.0
|
L
 -99.9%
H
0.1
2735.0
|
L
 -100.0%
H
0.1
468750
|
Revolution Medicines Inc |
|
7,097.9
|
38.0
|
L
 -0.9%
H
37.6
38.7
|
L
 2.6%
H
35.6
39.5
|
L
 2.6%
H
34
39.5
|
L
 -2.8%
H
34
42.4
|
L
 -9.2%
H
29.2
62.4
|
L
 81.6%
H
15.5
62.4
|
L
 32.3%
H
14.1
62.4
|
L
H
14.1
62.4
|
Upexi Inc |
|
423.8
|
7.2
|
L
 -10.6%
H
7.2
8
|
L
 -8.8%
H
7.1
9.1
|
L
 33.2%
H
4.3
9.1
|
L
 -26.7%
H
2.5
13.6
|
L
 76.8%
H
1.9
22.5
|
L
 -91.6%
H
1.9
114
|
L
H
1.9
187.4
|
L
H
1.9
187.4
|
Scinai Immunotherapeutics ... |
|
1.5
|
1.5
|
L
 4.8%
H
1.5
1.6
|
L
 -4.4%
H
1.5
1.6
|
L
 -23.5%
H
1.4
2.0
|
L
 -43.1%
H
1.4
6.2
|
L
 -61.0%
H
1.4
6.2
|
L
 -98.7%
H
1.4
118
|
L
 -100.0%
H
1.4
4989.6
|
L
 -99.6%
H
1.4
6200
|
FitLife Brands Inc |
|
174.9
|
18.6
|
L
 -0.3%
H
18.1
18.8
|
L
 9.5%
H
17.0
19.0
|
L
 41.8%
H
12.2
19.0
|
L
 23.3%
H
12.2
19.0
|
L
 -43.9%
H
9.8
35.5
|
L
 12.5%
H
9.8
35.5
|
L
 12.5%
H
9.8
35.5
|
L
 12.5%
H
9.8
35.5
|
Abivax - ADR |
|
6,123.7
|
81.0
|
L
 -0.8%
H
80.0
82.1
|
L
 4.9%
H
76.0
82.1
|
L
 16.1%
H
67.1
82.1
|
L
 1246.0%
H
5.7
82.1
|
L
 538.0%
H
4.8
82.1
|
L
H
4.8
82.1
|
L
H
4.8
82.1
|
L
H
4.8
82.1
|
Synergy CHC Corp |
|
22.8
|
2.4
|
L
 14.2%
H
2.1
2.5
|
L
 -17.7%
H
2.0
3.2
|
L
 -33.5%
H
2.0
4.0
|
L
 33.7%
H
1.7
4
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
iBio Inc |
|
16.1
|
0.8
|
L
H
0.8
0.8
|
L
 3.8%
H
0.8
0.9
|
L
 18.8%
H
0.6
0.9
|
L
 5.1%
H
0.6
1.1
|
L
 2.5%
H
0.6
1.1
|
L
 2.5%
H
0.6
1.1
|
L
 2.5%
H
0.6
1.1
|
L
 2.5%
H
0.6
1.1
|